Thai Union, S2G Ventures among new investors in aquaculture biotech firm ViAqua
Published on
June 10, 2021
Biotechnology company ViAqua Therapeutics announced that its recently-completed 4.3 million (EUR 3.5 million) funding round will be used to support the commercialization of its first product dedicated to improving shrimp health …
Photo courtesy of ViAqua Therapeutics
Share